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Background: Cardioembolism is among the most important causes of ischemic stroke around the world. A pilot 
double-center study evaluated the subtypes of cardioembolic mechanisms in stroke patients in two different 
racial subtypes. 
 
Methods: This prospective clinical study was conducted on 100 stroke patients in Mackenzie Hospital in Canada 
and 100 stroke patients who were age and sex matched in Ghaem Hospital in Mashhad, Iran in 2007. All of the 
Canadian patients were of white North American race and all of the Iranian ones of white Persian race. The 
diagnosis of ischemic stroke was made by stroke neurologists.  
Assessment of the cardioembolic mechanisms was made based on the standard method. The frequency of 
ischemic heart disease, congestive heart failure and atrial fibrillation was detected in the two studied groups.  
 
Results: 92 males and 108 females with ischemic stroke were studied. The influence of race on the frequency 
rate of ischemic heart disease, congestive heart failure and atrial fibrillation was not significant. However, rheu-
matic mitral valve disease was significantly more frequent among the Iranian group. The effect of race on the 
frequency rate of other cardioembolic mechanisms was not significant in each gender separately. However, atrial 
fibrillation was significantly more frequent in Canadian females. 
 
Conclusions: There was no significant difference in the frequency rate of cardioembolic mechanisms between 
North American and Persian stroke patients except for rheumatic mitral valve disease. 
 





The prevalence of stroke and its risk factors varies by 
race-ethnicity.1 It has been shown that modification of 
several major risk factors of stroke can reduce the inci-
dence of stroke. These differences are crucial to the eti-
ology of stroke and the design of stroke prevention pro-
grams.1 While a quarter of strokes are cardioembolic, 
the cardiac source of embolism is considered as a 
modifiable risk factor of stroke. The distribution of 
cardiac pathology as the cause of embolic stroke varies 
in different countries.2 Cardioembolic strokes repre-
sented 14% of the Stroke Data Bank,3 20% of the 
Lausanne Stroke Registry,4 and 25.6% of the German 
Stroke Data Bank.5 This pilot double-center study was 
designed for evaluation of cardioembolic mechanisms 
in patients with ischemic stroke. 
 
 
Materials and Methods 
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Walter Mackenzie Hospital in Canada and 100 con-
secutive ischemic stroke patients admitted in Ghaem 
Hospital in Iran were enrolled in this cross-sectional 
prospective study. The Canadian patients were of 
white North American race and the Iranian patients 
were of white Persian race. Ischemic stroke patients 
were age and sex matched in the two groups. The di-
agnosis of ischemic stroke was made by stroke neu-
rologists. Stroke was defined as an ischemic focal 
neurological deficit that persisted at least 24 hours.6 
All of the ischemic stroke patients had one or more 
control brain Computerized Tomography (CT) 48-
hour post-stroke.6 All of the ischemic stroke patients 
underwent a standard battery of etiologic investiga-
tions including ECG, blood electrolytes, blood count 
and differential coagulation profile, fasting blood 
sugar and lipid profile, duplex sonography of supra-
aortic trunks and transcranial doppler.6 The car-
dioembolic assessment included Electrocardiography 
(ECG), serum troponin, and transthoracic echocardi-
ography.7 A 24 hour, Holter monitoring was obtained 
in patients with a history of syncope and/or palpita-
tion with non-diagnostic ECG.7 Transesophageal 
echocardiography was performed in those for whom 
transthoracic echocardiography was non-diagnostic 
despite high suspicion of cardioembolism.7 Three se-
rial blood cultures were requested for any stroke pa-
tient with fever and heart murmur or valvular vegeta-
tion detected by echocardiography.7 Performing TEE, 
Holter monitoring and blood culture are not indicated 
in all stroke patients.6,7 There are ethics limitations to 
do expensive and semi-invasive TEE in the stroke 
patients only for research purposes. These differential 
levels of assessment are a standard protocol in the 
diagnostic workup of cardioembolic mechanism in 
stroke patients and do not influence the diagnoses.6,7 
Holter monitoring and transesophageal echocardi-
ography and blood culture were requested in 20%, 
14% and 8% of the patients, respectively. 
Cardioembolic mechanisms were detected by car-
diologists based on the clinical manifestations and 
diagnostic investigations. They were categorized as 
Ischemic Heart Disease (IHD), Congestive Heart 
Failure (CHF), Atrial Fibrillation (AF), and Rheu-
matic Mitral Valve Disease (RMVD). The effects of 
race and gender on the frequency of cardiac sources 
of embolism were analysed by Fisher Exact test and a 
p<0.05 was considered significant. The protocol was 
approved by our Institutional Ethics Committee and 
an informed consent was obtained from each subject 





200 ischemic stroke patients (92 males, 108 females) 
were evaluated. The mean age of the North American 
and Iranian stroke patients was 71.9 (SD=11.0) and 
68.7 (SD=5.3) years, respectively. In the Iranian group, 
IHD was found in 23% of the cases followed by AF 
(11%), RMVD (10%) and CHF (9%). In North Ameri-
can group, IHD was detected in 33% of the cases fol-
lowed by AF (18%), CHF (7%) and RMVD (2%). The 
effect of race on the frequency of IHD, AF and CHF in 
all of the stroke patients was not significant  
(df=1, p=0.115), (df=1, p=0.159) and (df=1, p=0.603), 
respectively. RMVD was significantly more frequent 
in the Iranian group (DF=1, p=0.017). Table 1 displays 
the effect of race on the frequency of cardioembolic 
mechanisms in each gender separately. Carotid steno-
sis more than 50% was found in 27 % of North Ameri-
can and 23 % of Iranian stroke patients which was not 





Comparisons of variability in the occurrence of stroke 
Table 1: Effect of race on the frequency rate of cardioembolic etiologies in each gender separately. Data are 




















Ischemic Heart Disease 31.5 24.1 34.8 21.8 Df=1 p=0.389 1, 0.165 
Atrial Fibrillation 25.9 11.1 8.7 2.2 Df=1 p=0.047 1, 0.5 
Congestive Heart Failer 9.3 5.5 4.3 13 Df=1, p=0.358 1, 0.133 
RMVD 3.7 11.1 0.0 8.7 Df=1 p=0.135 1, 0.058 
NA: North American   RMVD: Rheumatic Mitral Valve Disease 
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mechanism in different races are often confounded by 
factors other than racial differences.1 These include 
socioeconomic, lifestyle and nutritional factors as 
well as a variation in the frequency of risk factors in 
different racial groups.1 In recent years, attempts have 
been made to determine differences in frequency of 
stroke risk factors and etiologies in different racial 
groups in a single geographic location.1,2 Such re-
search indicates the contribution of these risk factor 
differences to variations in the frequency of stroke.1,2 
This research is designed to compare these differ-
ences in two Caucasian white races living in two dis-
tant continents. In our study groups, the effect of race 
subtypes and geographic differences on the frequency 
of cardioembolic mechanisms was only significant 
for RMVD in all of the stroke patients. It was found 
to be more frequent in Iranian stroke patients. Rheu-
matic heart disease is an important cause of mitral 
and aortic valve disease in developing countries.8,9 
Almost half of the cardioembolic strokes in devel-
oped countries are secondary to non-valvular AF and 
7.6% of cardioembolic mechanisms are due to rheu-
matic heart disease.10 In the Khorasan Stroke Registry 
Data Bank, rheumatic valvular disease comprised 
44.8 % of the cardioembolic mechanisms and caused 
4.3 preventable stroke cases per 100000 Iranians per 
year.6,7 RMVD was present in 63 % of Iranian stroke 
patients with atrial fibrillations.6,7 It has been reported 
as a common cause of stroke in Iran.11,12 Cardiac dis-
ease was found in 23% of Ethiopian stroke patients, 
and valvular heart disease comprised 40% of all heart 
diseases in these stroke patients.13 Distribution of IHD, 
AF and CHF was not significantly different between 
North American and Iranian stroke patients in our pilot 
double-center study. In an American epidemiologic 
study, Hispanics and Blacks were less likely than 
whites to report IHD.14 The Northern Manhattan 
Stroke Study revealed that AF, IHD and CHF were 
less prevalent in American Blacks and Hispanics.15 A 
Europian epidemiological study revealed that AF was 
significantly more frequent in female stroke patients.16 
The frequency of AF was significantly higher in our 
North American female stroke patients. The cause of 
this gender discripancy is unknown. Gender prepon-
derance to the other cardioembolic mechanisms was 
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